0001493152-24-046621.txt : 20241118
0001493152-24-046621.hdr.sgml : 20241118
20241118194025
ACCESSION NUMBER: 0001493152-24-046621
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20241108
FILED AS OF DATE: 20241118
DATE AS OF CHANGE: 20241118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lalonde James Joseph
CENTRAL INDEX KEY: 0002030844
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42204
FILM NUMBER: 241473012
MAIL ADDRESS:
STREET 1: 1895 LEXINGTON AVENUE
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invizyne Technologies Inc
CENTRAL INDEX KEY: 0002010788
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 834550057
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 ROYAL OAKS DR
CITY: MONROVIA
STATE: CA
ZIP: 91016
BUSINESS PHONE: (626) - 415 - 1488
MAIL ADDRESS:
STREET 1: 750 ROYAL OAKS DR
CITY: MONROVIA
STATE: CA
ZIP: 91016
3
1
ownership.xml
X0206
3
2024-11-08
0
0002010788
Invizyne Technologies Inc
IZTC
0002030844
Lalonde James Joseph
C/O 750 ROYAL OAKS DRIVE, SUITE 106
MONROVIA,
CA
91016
1
0
0
0
Stock Options for Common Stock
2.44
2021-02-01
2028-01-31
Common Stock
7791
D
Stock Options for Common Stock
8.00
2024-07-01
2031-03-31
Common Stock
51939
D
The options vest as follows: The first 130 shares vest per month starting February 1, 2021, and the balance vest at monthly basis thereafter, and become exercisable once vested. All shares are vested by 01/31/2026.
The options vest as follows: The first 2,597 shares vest on July 1, 2024, and the balance vest at the rate of 2,597 shares per quarter, commencing on October 1, 2024, and become exercisable once vested. All shares are vested by 03/31/2029.
/s/ James J. Lalonde
2024-11-08